The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...
Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...
GlobalData on MSN6d
EU’s Clinical Trials Regulation comes into full forceThe ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.
The government agency says X no longer suits its communication needs.
In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...
GlobalData on MSN1d
Italian charity seeks EMA approval for rescued gene therapyTelethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...
The European Medicines Agency (EMA) has decided to stop using the social media platform X due to content concerns and will instead use Bluesky. This move aligns with other organizations stepping back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback